Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C.

Rigamonti C, Vidali M, Donato MF, Sutti S, Occhino G, Ivaldi A, Arosio E, Agnelli F, Rossi G, Colombo M, Albano E.

Am J Transplant. 2009 Mar;9(3):601-9. doi: 10.1111/j.1600-6143.2008.02520.x. Epub 2009 Feb 3.

2.

Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C.

Sutti S, Vidali M, Mombello C, Sartori M, Albano E.

J Viral Hepat. 2010 Oct;17(10):685-90. doi: 10.1111/j.1365-2893.2010.01359.x.

PMID:
20738774
3.

Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C.

Vidali M, Occhino G, Ivaldi A, Serino R, Moia S, Alchera E, Carini R, Rigamonti C, Sartori M, Albano E.

J Hepatol. 2007 Apr;46(4):605-12. Epub 2006 Dec 6.

PMID:
17196701
4.

Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease.

Vidali M, Stewart SF, Rolla R, Daly AK, Chen Y, Mottaran E, Jones DE, Leathart JB, Day CP, Albano E.

Hepatology. 2003 Feb;37(2):410-9.

PMID:
12540792
5.

Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.

Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.

Liver Transpl. 2009 Jan;15(1):37-48. doi: 10.1002/lt.21566.

6.

The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.

Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, Lopez R, Zein NN.

Liver Transpl. 2008 Sep;14(9):1287-93. doi: 10.1002/lt.21524.

7.

Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry.

Sutti S, Vidali M, Mombello C, Sartori M, Ingelman-Sundberg M, Albano E.

J Hepatol. 2010 Sep;53(3):431-8. doi: 10.1016/j.jhep.2010.03.030. Epub 2010 May 31.

PMID:
20576306
8.

Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis.

McCarthy EK, Vakos A, Cottagiri M, Mantilla JJ, Santhanam L, Thomas DL, Amzel LM, Rose NR, Njoku DB.

mSphere. 2018 Oct 10;3(5). pii: e00453-18. doi: 10.1128/mSphere.00453-18. Erratum in: mSphere. 2018 Dec 5;3(6):. Mantila, Joel J [corrected to Mantilla, Joel J].

9.

Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode.

Lohse AW, Obermayer-Straub P, Gerken G, Brunner S, Altes U, Dienes HP, Manns MP, Meyer zum Büschenfelde KH.

J Hepatol. 1999 Jul;31(1):149-55.

PMID:
10424295
10.

Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients.

Herzog D, Soglio DB, Fournet JC, Martin S, Marleau D, Alvarez F.

Liver Transpl. 2008 Jul;14(7):946-55. doi: 10.1002/lt.21444.

11.

Progressive histological damage in liver allografts following pediatric liver transplantation.

Evans HM, Kelly DA, McKiernan PJ, Hübscher S.

Hepatology. 2006 May;43(5):1109-17.

PMID:
16628633
12.

Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.

Haufroid V, Ligocka D, Wallemacq P, Lison D, Horsmans Y.

Toxicol Lett. 2005 Jan 15;155(1):171-7.

PMID:
15585372
13.

Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.

Lytton SD, Helander A, Zhang-Gouillon ZQ, Stokkeland K, Bordone R, Aricò S, Albano E, French SW, Ingelman-Sundberg M.

Mol Pharmacol. 1999 Feb;55(2):223-33.

14.

The natural history of hepatitis C cirrhosis after liver transplantation.

Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.

Liver Transpl. 2009 Sep;15(9):1063-71. doi: 10.1002/lt.21784.

15.

A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.

Sugimura T, Obermayer-Straub P, Kayser A, Braun S, Loges S, Alex B, Lüttig B, Johnson EF, Manns MP, Strassburg CP.

Autoimmunity. 2002 Dec;35(8):501-13.

PMID:
12765476
16.

Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.

Salcedo M, Rodríguez-Mahou M, Rodríguez-Sainz C, Rincón D, Alvarez E, Vicario JL, Catalina MV, Matilla A, Ripoll C, Clemente G, Bañares R.

Liver Transpl. 2009 May;15(5):530-9. doi: 10.1002/lt.21721.

17.

Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.

Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N.

J Gastroenterol Hepatol. 2009 Apr;24(4):574-80. doi: 10.1111/j.1440-1746.2008.05638.x.

PMID:
19368635
18.

Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection.

Reiser M, Terrault N, Nelson DR, Mizokami M, Ferrell L, Lake JR, Roberts JP, Ascher NL, Wright TL, Lau JY.

Transplantation. 1997 Feb 27;63(4):609-12.

PMID:
9047160
19.

CYP2E1 autoantibodies in liver diseases.

Sutti S, Rigamonti C, Vidali M, Albano E.

Redox Biol. 2014;3:72-8. doi: 10.1016/j.redox.2014.11.004. Epub 2014 Nov 18. Review.

20.

Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.

Perrella A, Arenga G, Pisaniello D, Rampone B, Di Costanzo GG, Atripaldi L, Esposito C, Di Florio E, Perrella O, Cuomo O.

Transplant Proc. 2009 Jun;41(5):1761-6. doi: 10.1016/j.transproceed.2009.01.112.

PMID:
19545723

Supplemental Content

Support Center